Keywords: misrxing, cost, australia, 1b/year, inappropriate, prescribing, costing

MisRxing "could cost Australia A$1B/year"

Article | 17 March 2003

Inappropriate prescribing could be costing Australia's PharmaceuticalBenefits Scheme as much as A$1 billion ($614.6 million) a year, according to a study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in